Market Overview

Morning Market Movers

Share:
Related CYTR
CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer)
This Is A Near-Term Driver At CytRX
Related DM
Earnings Scheduled For February 6, 2015
Dominion Agrees To Acquire Carolina Gas Transmission

CytRx (NASDAQ: CYTR) rose 29.55% to 2.85 after the company reported that aldoxorubicin demonstrated statistically significant efficacy in the treatment of rapidly growing human brain cancer brains animals.

The Dolan Company (NYSE: DM) shares jumped 16.67% to $2.07 after the company announced its plans to sell two NDeX businesses.

Ambient (NASDAQ: AMBT) jumped 9.79% to $3.14 after the company reported that it has been awarded contract by Consolidated Edison.

WD-40 Company (NASDAQ: WDFC) moved up 8.71% to $62.67 on upbeat FQ3 earnings.

Posted-In: Morning Market MoversNews Intraday Update Markets

 

Related Articles (CYTR + AMBT)

Around the Web, We're Loving...

Get Benzinga's Newsletters